NOVERIS HEALTH SCIENCES by Noveris Health Sciences Inc. Financials - Benzinga

NOVERIS HEALTH SCIENCES by Noveris Health Sciences Inc.

MYCOFOTCPK

Trade with Public

Trade with Public

$0.7300

-0.07-8.75%

At close: Jul 22, 5:00 PM EST

Overview NewsFinancialsSentiment Compare

NOVERIS HEALTH SCIENCES by Noveris Health Sciences Inc. Financials

NOVERIS HEALTH SCIENCES by Noveris Health Sciences Inc. (MYCOF) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Mydecine's Q1 2023 Reports Shows Decline In Assets And R&D, Increase In Net Loss And Accumulated Deficit

Psychedelics biotech Mydecine Innovations Group (OTC: MYCOF) shared its condensed interim (unaudited) financial results for three months ended March 31, 2023. First quarter numbers:

Lara Goldstein

World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them

The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business landscape.

Lara Goldstein

Mydecine Innovations Group Reports Q2 Financial Results And Management Updates

After the resignation of several key board members on August 12, Mydecine Innovations Group (OTC: MYCOF) reported its financial results. For the period corresponding to the six months ended June 30, 2022: Total cash was $324,146

Lara Goldstein

Mydecine: Q3 Financials, Advances Research On Psychedelic Therapies For Mental Health & Addiction Disorders

Mydecine Innovations Group (NEO:MYCO) (OTC: MYCOF) (FSE:0NFA) reported its financial results on Tuesday and provided a business update for the third quarter ended September 30.

Jelena Martinovic

Mydecine Posts $26.9M Net Loss For 2020: What's Ahead For Psychedelic Stock

Denver-based Mydecine Innovations Group (NEO: MYCO) (Pink: MYCOF) released its 2020 yearly financial results this week, ending the year with $2.2 million in cash. The company reported having raised over $30 million more since the beginning of 2021.

Natan Ponieman

Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week, 4/20/2021

Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap.

The Cannabis Investor